These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10049240)

  • 1. Caz-hi, and extended-spectrum TEM beta-lactamase (TEM-61), is derived from Caz-lo (TEM-11) by in vivo selection.
    Claeys Geert ; De Baere T; Vaneechoutte M; Verschraegen G
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3328-9. PubMed ID: 10049240
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.
    Vuye A; Verschraegen G; Claeys G
    Antimicrob Agents Chemother; 1989 May; 33(5):757-61. PubMed ID: 2665644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.
    Gniadkowski M; Schneider I; Jungwirth R; Hryniewicz W; Bauernfeind A
    Antimicrob Agents Chemother; 1998 Mar; 42(3):514-20. PubMed ID: 9517925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
    Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.
    Rasmussen BA; Bradford PA; Quinn JP; Wiener J; Weinstein RA; Bush K
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1989-92. PubMed ID: 8239618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.
    Sirot D; Chanal C; Labia R; Meyran M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Oct; 24(4):509-21. PubMed ID: 2693430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
    Urban C; Mariano N; Rahman N; Queenan AM; Montenegro D; Bush K; Rahal JJ
    Microb Drug Resist; 2000; 6(4):297-303. PubMed ID: 11272258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae.
    Urban C; Meyer KS; Mariano N; Rahal JJ; Flamm R; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Feb; 38(2):392-5. PubMed ID: 8192474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity.
    Hibbert-Rogers LC; Heritage J; Todd N; Hawkey PM
    J Antimicrob Chemother; 1994 Apr; 33(4):707-20. PubMed ID: 8056689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
    Hoşoğlu S; Gündes S; Kolayli F; Karadenizli A; Demirdağ K; Günaydin M; Altindis M; Caylan R; Ucmak H
    Indian J Med Microbiol; 2007 Oct; 25(4):346-50. PubMed ID: 18087082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
    Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
    Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs.
    Fröhlich C; Sørum V; Thomassen AM; Johnsen PJ; Leiros HS; Samuelsen Ø
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
    Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.
    Pai H; Lyu S; Lee JH; Kim J; Kwon Y; Kim JW; Choe KW
    J Clin Microbiol; 1999 Jun; 37(6):1758-63. PubMed ID: 10325320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
    Clasen J; Birkegård AC; Græsbøll K; Folkesson A
    J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.